Intrust Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,160
Closed -$214K 388
2024
Q4
$214K Sell
1,160
-991
-46% -$191K 0.02% 373
2024
Q3
$424K Buy
2,151
+158
+8% +$32.8K 0.04% 278
2024
Q2
$412K Sell
1,993
-43
-2% -$9.74K 0.04% 274
2024
Q1
$552K Sell
2,036
-181
-8% -$43.2K 0.06% 236
2023
Q4
$524K Sell
2,217
-132
-6% -$26K 0.06% 237
2023
Q3
$460K Sell
2,349
-45
-2% -$9.24K 0.06% 246
2023
Q2
$503K Sell
2,394
-229
-9% -$45.6K 0.06% 243
2023
Q1
$529K Sell
2,623
-372
-12% -$84.3K 0.07% 231
2022
Q4
$653K Buy
2,995
+152
+5% +$33.2K 0.09% 195
2022
Q3
$559K Sell
2,843
-3
-0.1% -$648 0.09% 202
2022
Q2
$609K Sell
2,846
-201
-7% -$49.1K 0.09% 200
2022
Q1
$865K Sell
3,047
-99
-3% -$30.5K 0.11% 169
2021
Q4
$1.19M Buy
3,146
+33
+1% +$12.8K 0.14% 136
2021
Q3
$1.28M Sell
3,113
-60
-2% -$24.9K 0.17% 113
2021
Q2
$1.17M Buy
3,173
+38
+1% +$12.7K 0.16% 126
2021
Q1
$909K Buy
3,135
+128
+4% +$35.6K 0.13% 145
2020
Q4
$751K Buy
3,007
+20
+0.7% +$4.76K 0.11% 164
2020
Q3
$676K Sell
2,987
-11
-0.4% -$2.28K 0.12% 152
2020
Q2
$522K Buy
2,998
+136
+5% +$21.7K 0.1% 181
2020
Q1
$361K Sell
2,862
-300
-9% -$45K 0.1% 207
2019
Q4
$483K Buy
3,162
+136
+4% +$18.8K 0.11% 203
2019
Q3
$400K Buy
3,026
+27
+0.9% +$3.62K 0.1% 214
2019
Q2
$425K Buy
2,999
+73
+2% +$9.9K 0.1% 224
2019
Q1
$425K Sell
2,926
-18
-0.6% -$2.37K 0.11% 233
2018
Q4
$333K Buy
2,944
+599
+26% +$75K 0.1% 244
2018
Q3
$316K Buy
2,345
+277
+13% +$34.2K 0.08% 286
2018
Q2
$232K Buy
+2,068
New +$224K 0.06% 331

Other funds holding CRL